Cart
sales@molnova.com
SD 169
CAS No. 1670-87-7
SD 169( —— )
Catalog No. M20928 CAS No. 1670-87-7
SD 169 is a selective and ATP competitive the MAP kinases p38α and p38β?inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 27 | Get Quote |
|
| 25MG | 46 | Get Quote |
|
| 50MG | 72 | Get Quote |
|
| 100MG | 110 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSD 169
-
NoteResearch use only, not for human use.
-
Brief DescriptionSD 169 is a selective and ATP competitive the MAP kinases p38α and p38β?inhibitor.
-
DescriptionSD 169 is a selective and ATP competitive the MAP kinases p38α and p38β?inhibitor.
-
In VitroSD-169 significantly reduces p38 and HSP60 expression in T cells of the pancreatic beta islets.SD-169 demonstrates 38-fold potency against p38α MAP kinase (IC50=3.2 nM) than p38β MAP kinase (IC50=122 nM).
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1670-87-7
-
Formula Weight160.17
-
Molecular FormulaC9H8N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (624.30 mM)
-
SMILESNC(=O)c1ccc2[nH]ccc2c1
-
Chemical Name1H-Indole-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Myers R R Sekiguchi Y Kikuchi S et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration[J]. Experimental Neurology 2003 184(2):0-614.
molnova catalog
related products
-
SSK1
SSK1 is a compound that selectively kills senescent cells and is a precursor for β-galactosidase, which can reduce the inflammatory response of the body. SSK1 can activate the phosphorylation of p38 MAPK and MKK3/MKK6 in senescent cells, and promote mitochondrial DNA damage in senescent cells.
-
MW181 hydrochloride
MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.
-
DAMGO
DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents. Possible analgesic agent due to μ-opiod receptor interaction.
